Eli Lilly’s blockbuster weight loss drug Zepbound and diabetes treatment Mounjaro posted weaker-than-expected sales for …
Tag:
Lillys
-
-
-
Eli Lilly (LLY) shares soared Thursday, after the company’s second-quarter earnings surpassed expectations on booming …
-
Key Takeaways Eli Lilly received FDA approval for a drug to help treat Alzheimer’s on …
-
BusinessHealth CareNews
FDA approval of Eli Lilly’s Alzheimer’s drug cements our decision not to take profits
by adminEvery weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable …
-
Key Takeaways Eli Lilly is set to report earnings Tuesday as investors and analysts expect …
-
BusinessHealth CareNews
Promise of Eli Lilly’s weight-loss drug for sleep apnea adds reason to own
by adminEli Lilly ‘s weight-loss drug Zepbound showed promise as a treatment for sleep apnea — …
-
Key Takeaways Eli Lilly on Wednesday said its weight-loss treatment, Zepbound, was successful in helping …
-
BusinessHealth CareNews
Eli Lilly’s Zepbound, Mounjaro in short supply through June, FDA says
by adminAn injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York …
-
-
BusinessHealth CareNews
Here is Eli Lilly’s competitive edge in GLP-1 obesity drugs and Abbott’s secondary play
by adminEvery weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable …
-